Xcell Therapeutics Hits Upper Limit...Celemics·QuadMedicine ↑[K-Bio Pulse] 김승권 2026.02.06 오전 08:00 Bio Stocks Unfazed by ‘Black Monday’ Rout...Neurophet and BL Pharmtech Surge [K-Bio Pulse] 유진희 2026.02.03 오전 08:00 ABL Bio Slides on Sanofi Reprioritization...Stock Specific Risks Hit Biotechs[K-Bio Pulse] 김새미 2026.02.02 오전 08:10 MediPost hits limit on Japan valuation...Hyundai Bio rallies[K-Bio Pulse] 송영두 2026.01.28 오전 08:00 Investor Sentiment Lifted by Expectations of ‘Tangible Results’ Ensol Bio & L&K BioMed Surge[K-... 한광범 2026.01.26 오전 08:00 Investment Sentiment Shifts to Mid Risk...High Return Bio Stocks: Samyang Biopharm and U2Bio Surg... 유진희 2026.01.15 오전 08:10 Alteogen Sees Temporary Dip in Investor Sentiment Market Turns Cautious[K-Bio Pulse] 임정요 2026.01.23 오전 08:00 SyntekaBio Enters ‘Assetization Phase’ for AI Asset Program 송영두 2026.01.21 오전 09:27 Cellumed Hits Upper Limit on Hopes for Ownership Sale[K-Bio Pulse] 신민준 2026.01.20 오전 08:00 AI Drug Discovery & Medical Sectors Take Flight[K-Bio Pulse] 김승권 2026.01.14 오전 08:00 더 보기 로딩중..